1Raziorrouh B, Ulsenheimer A, Schraut W, et al. Inhibitory mole- cules that regulate expansion and restoration of HCVspecific CD4^+ T cells in patients with chronic infection[ J]. Gastroenterol- ogy,2011,141 (4) :1422 - 1431.
2Danilovic DL, Mendes-Correa MC, Lima EU,et al. Correlations of CTLA- 4 gene polymorphisms and hepatitis C chronic infection [ J ]. Liver Int,2012,32 (5) :803 - 808.
3Cheng PN, Wei YL, Chang TT, et al. Therapy with interferon - al- pha and ribavirin for chronic hepatitis C virus infection upregu- lates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells [ J ]. J Med Viro1.2008.80 ( 6 ) :989 - 996.
4Khorshied MM, Gouda HM, Khorshid OM, et al. Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma:an Egyptian study [ J ]. Leuk Lymphoma,2013 , 10 ( 3 ) :23 - 29.
5Maasoumy B, Cobb B, Bremer B,et al. Detection of low HCV vi- raemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir[ J]. Aliment Pharmacol Ther,2013 : Epub ahead of print.
6Esmat G, Elsharkawy A, E1 Akel W, et al. Fibroscan of chronic HCV patients coinfected with schistosomiasis. [ J~. Arab J Gastro- entero1,2013,14 ( 3 ) : 109 - 112.
